Efficacy of Photodynamic Therapy in Vulvar Lichen Sclerosus Treatment Based on Immunohistochemical Analysis of CD34, CD44, Myelin Basic Protein, and Ki67 Antibodies

Introduction: Lichen sclerosus (LS) is a chronic skin and mucosa inflammatory disease. It affects mainly the female anogenital area especially in postmenopausal period. The main symptoms include pruritus, burning, pain, sometimes urinary problems, or difficulties in defecation. Usually, porcelain-white plaques are seen in the skin and mucosa. The etiology and pathogenesis of LS are still uncertain. There are some research studies on possible genetic predisposition, yet autoimmune, hormonal, or infectious factors are not excluded. The typical treatment of LS is mainly pharmacological, although the alternative treatment method used in LS is photodynamic therapy (PDT), which is noninvasive technique based on selective destruction of lesions. Our study is focused on molecule markers of vascularisation (CD34), nervous cell function (myelin basic protein [MBP]), keratinocyte function (CD44), and proliferation index (Ki67) in cases treated with photodynamic method. Materials and Methods: A group of 100 patients treated in our department was included in the study. All 100 women had LS on the basis of clinical and histological criteria. All the subjects underwent PDT. In all cases, skin biopsies were taken before and after treatment, and samples were analyzed with CD34, CD44, MBP, and Ki67 antibodies using immunohistochemical staining. Results: The study shows the high efficacy of PDT in LS treatment including beneficial changes to CD34, CD44, and MBP immunostained molecules. The Ki67 proliferation index did not change significantly. A significant increase of CD34 (microvessel density), MBP, and CD44 expression was confirmed in the histological images and in the partial or full remission of clinical objective and subjective symptoms. Conclusions: The PDT is a very effective therapeutic method in LS treatment.

[1]  J. H. Price,et al.  Response of vulval lichen sclerosus and squamous hyperplasia to photodynamic treatment using sustained topical delivery of aminolevulinic acid from a novel bioadhesive patch system , 2009, Photodermatology, photoimmunology & photomedicine.

[2]  A. Morey,et al.  Lichen sclerosus: review of the literature and current recommendations for management. , 2007, The Journal of urology.

[3]  D. Morrell,et al.  Anogenital pruritus: lichen sclerosus in children. , 2007, Pediatric annals.

[4]  P. Pavanello,et al.  [Lichen sclerosus in children with phimosis]. , 2007, Minerva pediatrica.

[5]  S. Mordon,et al.  Intérêt et place de la thérapie photodynamique en gynécologie , 2007 .

[6]  J. Saurat,et al.  UVA and UVB Decrease the Expression of CD44 and Hyaluronate in Mouse Epidermis, which is Counteracted by Topical Retinoids , 2006, Photochemistry and photobiology.

[7]  S. Regauer Immune dysregulation in lichen sclerosus. , 2005, European journal of cell biology.

[8]  J. Saurat,et al.  Restored epidermal CD44 expression in lichen sclerosus et atrophicus and clinical improvement with topical application of retinaldehyde , 2005, The British journal of dermatology.

[9]  Wen-zhi Chen,et al.  Focused Ultrasound Therapy of Vulvar Dystrophies: A Feasibility Study , 2004, Obstetrics and gynecology.

[10]  A. Sieroń,et al.  [Photodynamic diagnosis and therapy in gynecology--current knowledge]. , 2004, Ginekologia polska.

[11]  C. Beham‐Schmid,et al.  [Vulvar lichen sclerosus. The importance of early clinical and histological diagnosis]. , 2004, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete.

[12]  C. Beham‐Schmid,et al.  Lichen sclerosus vulvae , 2003, Der Hautarzt.

[13]  W. Reid,et al.  The role of angiogenesis in vulvar cancer, vulvar intraepithelial neoplasia, and vulvar lichen sclerosus as determined by microvessel density analysis. , 2003, Gynecologic oncology.

[14]  J. Crow,et al.  The effect of topical corticosteroids on Ki67 and p53 expression in vulval lichen sclerosus , 2002, The British journal of dermatology.

[15]  J. Crow,et al.  Cell cycle proteins as molecular markers of malignant change in vulvar lichen sclerosus , 2001, International Journal of Gynecologic Cancer.

[16]  J. Saurat,et al.  Decrease in epidermal CD44 expression as a potential mechanism for abnormal hyaluronate accumulation in superficial dermis in lichen sclerosus et atrophicus. , 2000, The Journal of investigative dermatology.

[17]  D. Hall,et al.  Lichen sclerosus: early diagnosis is the key to treatment. , 1996, The Nurse practitioner.

[18]  M Landthaler,et al.  Topical photodynamic therapy in dermatology. , 1996, Journal of photochemistry and photobiology. B, Biology.

[19]  V. Loening-Baucke Lichen sclerosus et atrophicus in children. , 1991, American journal of diseases of children.

[20]  P. Carli,et al.  Lichen sclerosus and squamous hyperplasia of the vulva. A clinical study of medical treatment. , 1991, The Journal of reproductive medicine.

[21]  S. Mordon,et al.  [The place of photodynamic therapy in gynecology]. , 2007, Gynecologie, obstetrique & fertilite.

[22]  C. Kreibich,et al.  Lichen sclerosus , 2005, Archiv für Dermatologie und Syphilis.